Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Eplivanserin

X
Drug Profile

Eplivanserin

Alternative Names: Ciltyri; Sliwens; SR 46349; SR 46349B; SR 46615A

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator sanofi-aventis
  • Class Fluorobenzenes; Phenols; Sleep disorder therapies; Small molecules
  • Mechanism of Action Serotonin 2A receptor antagonists; Serotonin 5-HT2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders; Apnoea; Insomnia; Major depressive disorder; Myocardial infarction

Most Recent Events

  • 22 Dec 2009 Discontinued - Preregistration for Insomnia in European Union (PO)
  • 22 Dec 2009 Discontinued - Preregistration for Insomnia in USA (PO)
  • 16 Sep 2009 Sanofi-Aventis receives complete response letter from the US FDA for eplivanserin in Insomnia

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top